Soy protein firm Solbar has outlined big plans for growth in several fields, including dietary and sports nutrition following the completion of its acquisition by US-based farmer co-operative CHS in February 2012.
The new 6 million euro, EU backed satiety project will have a legacy long beyond its time-frame, as the collaborative effort looks to change the way the European market deals with the obesity crisis it faces.
Recommendations for dietary intake of vitamins and minerals may be helping to battle deficiencies, but they do not do enough to achieve optimal nutrition for brain health – suggesting a ‘growing case for supplementation’.
Sports and energy food and drink categories are blurring, according to Roberta Re, nutrition research manager at Leatherhead Food Research in this exclusive video from the Vitafoods 2012 trade show in Geneva.
With a recently awarded medical devices urinary tract infection (UTI) claim in the bag, Dutch start-up Medical Brands booked a late booth at Vitafoods Europe, keen to show off its achievement to a food sector that has been denied EU health claims.
Jarrow Rogovin, never a man to mince his words, says it is high time the IPA and other trade groups stepped up to the plate to defend a sector that has been under regulatory siege on both sides of the Atlantic for several years.
The second part of this exclusive interview sees Beneo executive board member, Yves Servotte, explaining the cooling but not crushing effect of EU prebiotic health claim rejections on its inulin-chicory business.
In the first part of this exclusive interview, Beneo Group executive board member, Yves Servotte, explains how European Union health claim rules have informed strategic thinking at one of Europe’s biggest and most vocal ingredient vendors.
How to demonstrate health benefits among healthy human beings? That is the challenge new European Union health claim laws have set contract research organisations (CROs) and others involved in trial design. A tough challenge yes, but not an insurmountable...
Dr Jacques Ravel, one the world’s leading vaginal microbia researchers, says revelations about differing ‘community types’ of vaginal bacteria could drastically improve treatments for the common condition, vaginosis.